HANDOK Inc. (KRX:002390)

Market Cap	157.45B
Revenue (ttm)	507.36B
Net Income (ttm)	-52.56B
Shares Out	13.76M
EPS (ttm)	-3,819.00
PE Ratio	n/a
Forward PE	n/a
Dividend	200.00 (1.75%)
Ex-Dividend Date	Feb 27, 2025

Volume	16,367
Average Volume	16,138
Open	11,230
Previous Close	11,290
Day's Range	11,210 - 11,470
52-Week Range	11,060 - 20,300
Beta	0.60
RSI	47.91
Earnings Date	Mar 12, 2025

About HANDOK

HANDOK Inc. operates as a pharmaceutical company. The company provides ETC and OTC drugs; and medical devices and research products, including blood pressure monitors, cholesterol monitoring systems, insulin pumps, self monitoring system of blood glucose, and blood glucose monitoring system. It focuses on various therapeutic areas, such as oncology, diabetes and metabolic disorders, CNS, orphan diseases, eye disorders, and other disease areas. The company also offers healthcare products comprising food supplements under the NatureSet brand; foo...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1954
• Employees: 941
• Stock Exchange: Korea Stock Exchange
• Ticker Symbol: 002390

Financial Performance

In 2024, HANDOK's revenue was 507.36 billion, a decrease of -2.94% compared to the previous year's 522.74 billion. Losses were -52.56 billion, 82.5% more than in 2023.